Basis of Presentation and Summary of Significant Accounting Policies (Tables)

3 Months Ended

Dec. 31, 2024

Basis of Presentation and Summary of Significant Accounting Policies

Schedule of computation of basic and diluted earnings per share

	Three months ended December 31,
	2024		2023
Numerator:
Net income (loss) attributable to common stockholders	$	17,377,614	$	(11,178,239)
Effect of dilutive securities:
(Gain) loss from change in fair value of warrant liability		—		—
Loss from change in fair value of promissory notes		—		—
Adjusted net income (loss) attributable to common stockholders	$	17,377,614	$	(11,178,239)
Denominator:
Weighted average shares outstanding, basic		24,233,957		13,012,833
Effect of dilutive securities:
Common stock warrants		—		—
Convertible promissory notes		—		—
Dilutive effect of stock options		—		—
Weighted average shares outstanding, diluted		24,233,957		13,012,833
Basic net income (loss) per share	$	0.72	$	(0.86)
Diluted net income (loss) per share	$	0.72	$	(0.86)

Schedule of anti-dilutive securities

	As of December 31,
	2024		2023
Performance-based stock units	—		123
Performance-based stock options	190,000		35,000
Stock options	2,816,851		1,299,105
Common stock warrants	14,193,772	(i)	366,427
Convertible debt	1,191,479	(ii)	875,970

(i) Refer to Note 11 for disclosures on the warrant inducement transactions entered into in January 2025.

(ii) The calculation for potentially dilutive securities pertaining to convertible debt is as follows: $3,750,000 of outstanding principal and accrued interest as of December 31, 2024, is converted at a rate of $7.00, and the remaining amount is converted based on a fixed conversion price of $40.00 per share, which is subject to change as described in Note 7.